Abstract:siRNA-based therapeutics possess great potential to treat a wide variety of genetic disorders. However, they suffer from low cellular uptake and short half-lives in blood circulation; issues that remain to be addressed. This work is, to the best of our knowledge, the first to report the production of solid nano-in-nanoparticles, termed double nano carriers (DNCs) by means of the innovative technology of nano spray drying. DNCs (with a median size of 580-770nm) were produced by spraying at low temperatures (50°C) to prevent damage to heat-sensitive biomacromolecules like siRNA. DNCs consisting of Poly (d,l-lactide-co-glycolide) used as a wall material, encapsulating 20% human serum albumin primary nanoparticles (PNPs) loaded with siRNA, were obtained as a dry nanoparticulate powder with smooth spherical surfaces and a unique inner morphology. Incubation of pegylated or non-pegylated DNCs under sink conditions at 37°C, elicited a controlled release profile of the siRNA for up to 12 or 24h, respectively, with a minimal burst effect. Prolonged incubation of pegylated DNCs loaded with active siRNA (anti EGFR) in an A549 epithelial cell culture monolayer did not induce any apparent cytotoxicity. A slow degradation of the internalized DNCs by the cells was also observed resulting in the progressive release of the siRNA for up to 6days, as corroborated by laser confocal microscopy. The structural integrity and silencing activity of the double encapsulated siRNA were fully preserved, as demonstrated by HPLC, gel electrophoresis, and potent RNAi activity of siRNA extracted from DNCs. These results demonstrate the potential use of DNCs as a nano drug delivery system for systemic administration and controlled release of siRNA and potentially other sensitive bioactive macromolecules.

Two Birds with One Stone: A Novel Dithiomaleimide-Based GalNAc-siRNA Conjugate Enabling Good siRNA Delivery and Traceability

Novel diamine-scaffold based N-acetylgalactosamine (GalNAc)-siRNA conjugate: synthesis and in vivo activities

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates

Redox-Responsive Polymeric RNAi Based on Multivalent Conjugation of siRNA for Improved Intracellular Delivery.

GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Aptamer-functionalized silver nanoclusters-mediated cell type-specific siRNA delivery and tracking

Ph-Sensitive Nanomicelles for High-Efficiency Sirna Delivery in Vitro and in Vivo: an Insight into the Design of Polycations with Robust Cytosolic Release

Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases

An ionizable supramolecular dendrimer nanosystem for effective siRNA delivery with a favorable safety profile

A Novel Gemini-Like Cationic Lipid For The Efficient Delivery Of Sirna

Ligand conjugate SAR and enhanced delivery in NHP

Gadolinium Embedded Iron Oxide Nanoclusters As T1-T2 Dual-Modal MRI-visible Vectors for Safe and Efficient Sirna Delivery.

Cell Type-Specific Delivery of RNAi by Ligand-Functionalized Curdlan Nanoparticles: Balancing the Receptor Mediation and the Charge Motivation

The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates

Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery

Solid nano-in-nanoparticles for potential delivery of siRNA

SiRNA Delivery Systems Based on Neutral Cross-Linked Dendrimers.

Carbon Dots with Guanidinium and Amino Acid Functional Groups for Targeted Small Interfering RNA Delivery toward Tumor Gene Therapy (Small 31/2023)

Carbon Dots with Guanidinium and Amino Acid Functional Groups for Targeted Small Interfering RNA Delivery toward Tumor Gene Therapy.

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates

AIE Featured Inorganic-Organic Core@Shell Nanoparticles for High-Efficiency Sirna Delivery and Real-Time Monitoring